Nexalin Technology (NXL) Non-Current Assets (2021 - 2026)

Nexalin Technology's (NXL) quarterly Non-Current Assets came in at $404479.0 in Q1 2026, up 44.7% year-on-year from $279520.0 in Q1 2025, and up 20.36% quarter-over-quarter from $336049.0 in Q4 2025.

Nexalin Technology (NXL) Non-Current Assets (2021 - 2026) Analysis & Trends

Nexalin Technology's Non-Current Assets history runs 6 years deep, the most recent figure standing at $404479.0 for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 44.7% year-over-year to $404479.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 5.68% increase from a year earlier, with the FY2025 full-year figure at $336049.0, up 28.46% from the prior year.
  • Non-Current Assets grew to $404479.0 in Q1 2026 per NXL's latest filing, from $336049.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $404479.0 in Q1 2026 and bottomed at $6674.0 in Q4 2022.
  • The 5-year median for Non-Current Assets is $270957.0 (2024), against an average of $226154.0.
  • Across the five-year window, Non-Current Assets soared 2927.03% in 2023 and retreated 22.6% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $6674.0 in 2022, then surged by 2927.03% to $202024.0 in 2023, then grew by 29.49% to $261591.0 in 2024, then gained by 28.46% to $336049.0 in 2025, then gained by 20.36% to $404479.0 in 2026.
  • Per Business Quant, the three latest NXL Non-Current Assets figures stand at $404479.0 (Q1 2026), $336049.0 (Q4 2025), and $308562.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 84.92 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 32.95 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 68.24 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 35.67 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 7.09 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 2.30 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 20.47 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 26.70 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 6.35 Bn
10 Nexalin Technology 9.32 Mn 6.61 Mn 13,133.00 404,479.00

Historic Data

Download Data
DateValue
Mar 31, 2026 404,479.00
Dec 31, 2025 336,049.00
Sep 30, 2025 308,562.00
Jun 30, 2025 294,871.00
Mar 31, 2025 279,520.00
Dec 31, 2024 261,591.00
Sep 30, 2024 349,593.00
Jun 30, 2024 380,983.00
Mar 31, 2024 270,957.00
Dec 31, 2023 202,024.00
Sep 30, 2023 170,418.00
Jun 30, 2023 63,737.00
Mar 31, 2023 54,704.00
Dec 31, 2022 6,674.00
Sep 30, 2022 8,148.00
Dec 31, 2021 1,039.00